There is a problem at the other end, after the clinical trials, if a problem is found in use. There were complaints about memory damage for Lipitor for over a

There is a problem at the other end, after the clinical trials, if a problem is found in use. There were complaints about memory damage for Lipitor for over a decade, without public warnings (the warnings came recently, a while after the patents timed out). If this had been found in the human trials, I doubt it would have been let through. I do wonder if the large amount of money from selling the drug (a big bestseller) had influence on any decision... Nah, regulatory capture is a myth re the medical industry, they wouldn't sell out our health, would they?